Cart is empty Researchers at Umeå University, Sweden, have found another piece of the puzzle that explains why there are differences in immune responses in women and men when they get sick with COVID-19. This discovery has implications for treatment strategies for severe COVID-19.
Study finds proinflammatory diets worsen gum disease and boost inflammation over time
New research presented at EuroPerio11 sheds light on the profound connections between diet, inflammation, and gum health. Three studies explore how dietary choices influence systemic inflammation, the effectiveness of periodontal therapy, and the benefits of avoiding sugar on oral and overall health.
Lower tackle height is changing face of women’s rugby, study says
Lowering the legal tackle height in women’s rugby is proving effective in reducing head contacts between players, a novel study suggests. The paper is published in the journal BMJ Open Sport & Exercise Medicine.
Vaccine that protects against swine, human and bird flu could eliminate need for yearly shots
Annual flu shots could become a thing of the past under a new vaccine strategy developed and tested by University of Nebraska–Lincoln virologist Eric Weaver and his laboratory team.
Trust is vital in managing future pandemics, says Australian study
A Burnet study published today in the Medical Journal of Australia, titled “Preparing Australia for future pandemics: strengthening trust, social capital and resilience,” discusses the need for the Australian Government to rebuild trust and prioritize assistance for priority communities ahead of future pandemics.
Telemedicine and new scoring system offer hope for safer post-stroke hypertension management
In a significant advancement in stroke care, researchers from HKU Stroke and the Department of Medicine, School of Clinical Medicine at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have developed the TRICH score.
Experimental compound targets circadian clock machinery in cells to fight glioblastoma
A series of preclinical studies show that a new compound, SHP1705, targets circadian clock proteins hijacked by glioblastoma stem cells, impairing the cancer cells’ ability to survive and grow. SHP1705 is also the first clock-targeting compound to complete a phase 1 clinical trial, where it was found to be safe and well-tolerated in humans. A summary of the research is published in the journal Neuro-Oncology.
Estrogen-related receptors could be key to treating metabolic and muscular disorders
A new Salk Institute study suggests that estrogen-related receptors could be a key to repairing energy metabolism and muscle fatigue.
Vitamin supplements and cancer: New study warns against unsupervised nutritional interventions
A new study coordinated by Dr. Salvatore Cortellino and Professor Antonio Giordano, President of the Sbarro Health Research Organization (SHRO) and molecular oncologist at Temple University and the University of Siena, offers a critical assessment of vitamin supplementation and popular dietary trends in the context of cancer prevention and treatment.
When doctors dismiss symptoms, patients can suffer lasting harm
A review by Rutgers Health researchers reveals the psychological damage and health care avoidance that may occur when doctors dismiss, minimize or ignore patients’ symptoms, a phenomenon medical scientists call “symptom invalidation” and patients often call “medical gaslighting.”